Open Access Article
This Open Access Article is licensed under a Creative Commons Attribution 3.0 Unported Licence
Correction: Amenamevir by Ugi-4CR
Xin
Li
a,
Tryfon
Zarganes-Tzitzikas
b,
Katarzyna
Kurpiewska
c and
Alexander
Dömling
*a
aUniversity of Groningen, Department of Drug Design, A. Deusinglaan 1, Groningen, The Netherlands. E-mail: a.s.s.domling@rug.nl
bAlzheimer's Research UK Oxford Drug Discovery Institute, University of Oxford, Oxford, OX3 7FZ, UK
cJagiellonian University, Faculty of Chemistry, Department of Crystal Chemistry and Crystal, Physics, Biocrystallography Group, Gronostajowa 2, 30-387 Krakow, Poland
First published on 3rd May 2023
Abstract
Correction for ‘Amenamevir by Ugi-4CR’ by Xin Li et al., Green Chem., 2023, 25, 1322–1325, https://doi.org/10.1039/D2GC04869H.
The authors regret that there was an inaccuracy present in the affiliation information for one of the authors, Alexander Dömling, in the original manuscript.
The work was performed at the Department of Drug Design, University of Groningen, Groningen, The Netherlands (a.s.s.domling@rug.nl) before the transition of Alexander Dömling to their current institution, CATRIN, Innovative Chemistry Group, Palacký University Olomouc, Olomouc, Czech Republic (alexander.domling@upol.cz). The corrected list of author information and affiliations for this article is as shown here.
The Royal Society of Chemistry apologises for these errors and any consequent inconvenience to authors and readers.
| This journal is © The Royal Society of Chemistry 2023 |